Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
+10.34%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$5.32B
AUM Growth
+$623M
(+13%)
Cap. Flow
+$354M
Cap. Flow
% of AUM
6.65%
Top 10 Holdings %
Top 10 Hldgs %
31.02%
Holding
1,573
New
308
Increased
332
Reduced
859
Closed
60
Top Buys
| 1 |
Equinix
EQIX
|
+$41.9M |
| 2 |
American Tower
AMT
|
+$33.5M |
| 3 |
CD
Chindata Group Holdings Limited American Depositary Shares
CD
|
+$28M |
| 4 |
Crown Castle
CCI
|
+$20.9M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$13.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$89.3M |
| 2 |
Microsoft
MSFT
|
+$66.1M |
| 3 |
Amazon
AMZN
|
+$63.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$26.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$25.2M |
Sector Composition
| 1 | Real Estate | 18.33% |
| 2 | Technology | 16.47% |
| 3 | Consumer Discretionary | 8.8% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Wheaton Precious Metals
WPM
$47.5B
| $147K | ﹤0.01% |
+3,510
| New | +$147K |
|
1152
BioMarin Pharmaceuticals
BMRN
$10.7B
| $146K | ﹤0.01% |
1,665
-11,832
| -88% | -$1.04M |
|
|
ARNA
1153
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $146K | ﹤0.01% |
1,906
+192
| +11% | +$14.7K |
|
1154
Dropbox
DBX
$8.42B
| $144K | ﹤0.01% |
6,498
+576
| +10% | +$12.8K |
|
1155
Agnico Eagle Mines
AEM
$76.7B
| $142K | ﹤0.01% |
+2,011
| New | +$142K |
|
1156
BioXcel Therapeutics
BTAI
$52.1M
| $142K | ﹤0.01% |
192
+96
| +100% | +$71K |
|
1157
Sarepta Therapeutics
SRPT
$1.85B
| $141K | ﹤0.01% |
829
+168
| +25% | +$28.6K |
|
|
GBT
1158
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $141K | ﹤0.01% |
3,250
+1,574
| +94% | +$68.3K |
|
1159
Tenaris
TS
$18.3B
| $140K | ﹤0.01% |
+8,794
| New | +$140K |
|
|
CCXI
1160
DELISTED
ChemoCentryx, Inc.
CCXI
| $140K | ﹤0.01% |
2,259
+644
| +40% | +$39.9K |
|
1161
CareDx
CDNA
$716M
| $139K | ﹤0.01% |
1,912
-582
| -23% | -$42.3K |
|
1162
Denali Therapeutics
DNLI
$2.25B
| $139K | ﹤0.01% |
1,656
-214
| -11% | -$18K |
|
1163
Macerich
MAC
$4.57B
| $139K | ﹤0.01% |
12,982
-15,109
| -54% | -$162K |
|
1164
Neurocrine Biosciences
NBIX
$14.3B
| $139K | ﹤0.01% |
1,455
+542
| +59% | +$51.8K |
|
1165
Acadia Pharmaceuticals
ACAD
$4.19B
| $138K | ﹤0.01% |
2,584
+294
| +13% | +$15.7K |
|
1166
Amicus Therapeutics
FOLD
$2.43B
| $138K | ﹤0.01% |
5,986
-3,632
| -38% | -$83.7K |
|
1167
Greif
GEF
$3.5B
| $138K | ﹤0.01% |
2,939
-3,423
| -54% | -$161K |
|
1168
Vera Bradley
VRA
$64.2M
| $138K | ﹤0.01% |
+17,298
| New | +$138K |
|
1169
Natera
NTRA
$24.2B
| $136K | ﹤0.01% |
1,362
-1,204
| -47% | -$120K |
|
1170
News Corp Class B
NWS
$18.3B
| $136K | ﹤0.01% |
7,678
-901
| -11% | -$16K |
|
1171
Rogers Communications
RCI
$19.2B
| $136K | ﹤0.01% |
+2,921
| New | +$136K |
|
|
XLRN
1172
DELISTED
Acceleron Pharma Inc.
XLRN
| $136K | ﹤0.01% |
1,060
-44
| -4% | -$5.65K |
|
1173
Exact Sciences
EXAS
$10.5B
| $135K | ﹤0.01% |
1,019
-210
| -17% | -$27.8K |
|
|
TPTX
1174
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $135K | ﹤0.01% |
1,111
| – | – |
|
|
BLUE
1175
DELISTED
bluebird bio
BLUE
| $134K | ﹤0.01% |
240
+113
| +89% | +$63.1K |
|